Mammotome Announces the Launch of the Mammotome DualCore™ Dual Stage Core Biopsy System

August 25, 2022

Mammotome Announces the Launch of the Mammotome DualCore™ Dual Stage Core Biopsy System

CINCINNATI, OHIO – August 25, 2022 – Mammotome is excited to announce the launch of the Mammotome DualCore™ biopsy system, the company’s first dual stage core biopsy instrument. This new core biopsy device provides another option in the Mammotome ultrasound-guided breast biopsy portfolio, which also includes the Mammotome® Elite Tetherless Vacuum-Assisted Biopsy Device (tetherless VABB) and the Mammotome Revolve™ Dual Vacuum-Assisted Breast Biopsy System (tethered VABB).

As a global leader in the breast care space, Mammotome is committed to providing exceptional breast biopsy technologies that are designed to meet the needs of both clinicians and patients. The Mammotome DualCore™ biopsy system offers clinicians three programable firing modes and easy one-handed operation, features that make it simple to access even the most challenging lesions. The device’s lightweight, ergonomic and smart design also minimizes needle movements and vibrations, helping to improve the overall patient experience.

The Mammotome DualCore™ biopsy system can be paired with the company’s innovative breast biopsy markers to provide clinicians with comprehensive and unique ultrasound breast biopsy solutions. The Mammotome portfolio includes one of the top-selling tissue marker brands globally, the HydroMARK™ breast biopsy site marker, which is known for its long-term ultrasound visibility.

“I am excited to start using the Mammotome DualCore™ biopsy system for core needle biopsies,” said radiologist Dr. Christine Ormsby of Mercy Hospital Jefferson. “It’s lightweight and easy to handle and see under ultrasound. The Mammotome DualCore™ system pairs especially well with the HydroMARK™ biopsy clip, which offers superb ultrasound visibility.”

The Mammotome DualCore™ biopsy system is now available to clinicians in the United States and Canada.

Media Contact: Erica Bednar, Director of Marketing Communications
Phone: 513-391-4737
[email protected]

About Mammotome

At Mammotome, our expertise and compassion make us an indispensable partner to clinicians and patients. Our drive for innovation is rivaled only by our empathy for the people we serve, from the clinicians who demand consistently precise solutions to the patients and families seeking peace of mind. We boast a comprehensive array of products that create better outcomes in breast care and provide physicians and patients with educational resources that guide their journey. Headquartered in Cincinnati, OH, Mammotome has been part of the Danaher Corporation since 2014. The Mammotome brand of products is sold in over 50 different countries around the world.

###

©2022 Devicor Medical Products, Inc. All rights reserved. Devicor, Mammotome, Mammotome Elite, Mammotome Revolve and HydroMARK are registered trademarks of Devicor Medical Products, Inc., in the USA and optionally in other countries. Mammotome DualCore is a trademark of Devicor Medical Products, Inc., in the USA and optionally in other countries. Other logos, product and/or company names might be trademarks of their respective owners. MDM# 220664 Rev 8/22